Yorke Justin W
SEC CIK 1361896 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | Dir | 353 | $31.4K | $52.5K | 16 | 2021-08-05 | 2026-06-26 |
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-30 16:49 | 2026-06-26 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | M - OptEx | — | +203 | 353 | +135% | — |
| I | 2025-01-31 | 2025-01-27 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | P - Purchase | $0.8 | +12.4K | 12.4K | New | +$9,920 |
| I | 2024-01-31 | 2024-01-30 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | P - Purchase | $2.69 | +8,000 | 31.2K | +34% | +$21.5K |
| I | 2023-11-28 | 2023-11-21 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | J - Other | $0.00 | -55.3K | 464.6K | -11% | $0 |
| A | 2023-10-23 | 2023-10-12 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | A - Grant | $0.3 | +6,000 | 74.7K | +9% | +$1,800 |
| 2023-10-12 | 2023-10-12 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | A - Grant | $0.3 | +6,000 | 75.7K | +9% | +$1,800 | |
| 2023-10-10 | 2023-10-10 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | A - Grant | $0.21 | +12.0K | 69.7K | +21% | +$2,520 | |
| D | 2023-07-24 | 2023-06-27 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | M - OptEx | — | +23.6K | 56.7K | +71% | — |
| A | 2023-01-04 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | M - OptEx | — | +1,169 | 14.9K | +9% | — |
| D | 2023-01-04 | 2022-12-31 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | A - Grant | — | +18.2K | 33.1K | +122% | — |
| 2022-08-09 | 2022-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | A - Grant | — | +4,393 | 13.7K | +47% | — | |
| 2022-04-04 | 2022-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | A - Grant | — | +4,393 | 13.7K | +47% | — | |
| I | 2022-01-31 | 2022-01-27 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | S - Sale | $3.30 | -1,854 | 532.6K | -0.3% | -$6,118 |
| MI | 2021-12-07 | 2021-12-03+ | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | S - Sale | $4.78 | -9,700 | 534.4K | -2% | -$46.4K |
| A | 2021-09-01 | 2021-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | A - Grant | — | +1,169 | 9,323 | +14% | — |
| 2021-08-09 | 2021-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Yorke Justin W | Dir | A - Grant | — | +1,169 | 301.9K | +0.4% | — |
Purchase Sale Sale after option exercise All abbreviations